NEW YORK, August 5, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please
scroll to bottom.
Today, Investors' Reports announced new research reports
highlighting Trius Therapeutics, Inc. (NASDAQ: TSRX), HCA Holdings,
Inc. (NYSE: HCA), Alere Inc. (NYSE: ALR), Universal Health Services
Inc. (NYSE: UHS), and Bio-Reference Laboratories Inc. (NASDAQ:
BRLI). Today's readers may access these reports free of charge -
including full price targets, industry analysis and analyst ratings
- via the links below.
Trius Therapeutics, Inc. Research
Report
On July 30, 2013, Trius
Therapeutics Inc. (Trius) and Cubist Pharmaceuticals Inc. (Cubist)
jointly announced a definitive agreement under which Cubist will
acquire all outstanding shares of Trius for $13.50 per share in cash or nearly $707 million on a fully diluted basis.
Jeffrey Stein, Ph.D., President and
Chief Executive Officer of Trius, said, "This transaction
culminates years of intense work by the Trius team to achieve this
outcome, and our shareholders are being rewarded for their
involvement and support of the company." According to the
Companies, the agreement includes each Trius stockholder to receive
one Contingent Value Right (CVR), entitling the holder to receive
an additional cash payment of up to $2.00 for each share they own if certain
commercial sales milestones are achieved. The Full Research Report
on Trius Therapeutics, Inc. - including full detailed breakdown,
analyst ratings and price targets - is available to download free
of charge at:
[http://www.investorsreports.com/report/2013-08-01/TSRX]
--
HCA Holdings, Inc. Research Report
On July 29, 2013, HCA Holdings,
Inc. (HCA) announced the retirement of Richard M. Bracken as Chairman and Chief
Executive Officer of the Company, who will now transition as the
Chairman of the Board at the end of 2013. R. Milton Johnson will assume the position of
HCA's Chief Executive Officer, effective that same time. Bracken
joined HCA in 1981 and has held several executive leadership roles
within the Company while Johnson has served the Company for 31
years. Johnson was named a member of the Company's Board of
Directors in 2009 and assumed his current role as President in
2011. The Full Research Report on HCA Holdings, Inc. - including
full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.investorsreports.com/report/2013-08-01/HCA]
--
Alere Inc. Research Report
On July 31, 2013, Alere Inc.
(Alere) announced its Q2 2013 financial results posting net revenue
of $764 million compared to
$700.5 million in Q2 2012. Net loss
attributable to common stockholders of the Company was $65.9 million or $0.81 per diluted share, compared to $18.2 million or $0.23 in Q2 2012. Non-GAAP adjusted net income
per diluted share was $0.64 compared
to $0.48 in Q2 2012. Ron Zwanziger,
Chairman, Chief Executive Officer and President of Alere, said, "We
are pleased to report a very strong quarter for Alere and continued
progress against the three-point strategic plan that we implemented
in November 2012. In particular, our
currency adjusted organic growth rate for our professional
diagnostics segment, excluding changes in our U.S. Triage and
influenza revenues, was 8.6%, reflecting the strength of our
highly-differentiated portfolio across the globe. In addition, our
combined adjusted research and development and selling, general and
administrative expenses decreased as a percentage of revenue by 230
basis points from the prior year quarter. Our growth rate in the
quarter, coupled with disciplined expense control, demonstrates our
continued momentum and commitment to enhancing value for our
shareholders." The Full Research Report on Alere Inc. - including
full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.investorsreports.com/report/2013-08-01/ALR]
--
Universal Health Services Inc.
Research Report
On July 25, 2013, Universal Health
Services, Inc. (UHS) announced its Q2 2013 financial results,
reporting net income attributable to UHS of $151.8 million or $1.53 per diluted share compared to $197.6 million or $1.10 per diluted share in Q2 2012. Reported net
revenues were up 6.5% YoY to $1.8
billion. The Acute Care Services net revenues increased 4.9%
YoY, whereas its Behavioral Health Care Services net revenues
increased 3.2% YoY. For H1 2013, the Company reported net revenues
of $3. 7 billion, compared to
$3.5 billion in H1 2012. The Full
Research Report on Universal Health Services Inc. - including full
detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.investorsreports.com/report/2013-08-01/UHS]
--
Bio-Reference Laboratories Inc.
Research Report
On July 22, 2013, Bio-Reference
Laboratories Inc. (Bio-reference) announced that it has signed a
licensing agreement with the University of
Washington to make GeneTests.org, GeneClinics.org and all
other related properties to become a business unit of
Bio-Reference. Vice President of Marketing for Bio-Reference,
Amar Kamath, commented, "We
recognized that GeneTests.org has been providing a community
service since molecular genetics was in its infancy, and we're
pleased to be preserving and maintaining this valuable resource
free-of-charge to users." According to the Company, GeneTests.org
has been a main resource for physicians, geneticists and genetic
counselors seeking comprehensive information about testing for
inherited disorders and genetic counseling services since 1992. The
Full Research Report on Bio-Reference Laboratories Inc. - including
full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.investorsreports.com/report/2013-08-01/BRLI]
----
EDITOR NOTES:
- This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a
best efforts basis and reviewed by a CFA. However, we are only
human and are prone to make mistakes. If you notice any errors or
omissions, please notify us below.
- This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
- If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco@EquityNewsNetwork.com.
- For any urgent concerns or inquiries, please contact us
at compliance@EquityNewsNetwork.com.
- Are you a public company? Would you like to see similar
coverage on your company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort
basis. This document, article or report is prepared and authored by
Equity News Network. An outsourced research services provider has,
through Chartered Financial Analysts, only reviewed the information
provided by Equity News Network in this article or report according
to the Procedures outlined by Equity News Network. Equity News
Network is not entitled to veto or interfere in the application of
such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as
to the accuracy or completeness or fitness for a purpose
(investment or otherwise), of the information provided in this
document. This information is not to be construed as personal
financial advice. Readers are encouraged to consult their personal
financial advisor before making any decisions to buy, sell or hold
any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may
be occasioned at the time of printing of this document or any
error, mistake or shortcoming. No liability is accepted by Equity
News Network whatsoever for any direct, indirect or consequential
loss arising from the use of this document. Equity News Network
expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance
placed on the information in this document. Equity News Network
does not (1) guarantee the accuracy, timeliness, completeness or
correct sequencing of the information, or (2) warrant any results
from use of the information. The included information is subject to
change without notice.
InvestorsReports.com
SOURCE Investors' Reports